Acacia Pharma Group Plc
Acacia Pharma Group Plc
  • Products
    • Overview
    • Therapeutic Areas
    • Marketed Products
    • APD403
  • Partnering
  • Media
    • Press Releases
    • Events
  • Investors
    • Overview
    • Regulatory Announcements
    • Shareholding Structure
    • Share Information
    • Share Price and Charts
    • Financial Reports and Presentations
    • Shareholder Meetings
    • Financial Calendar
    • Analysts
    • Corporate Governance
    • California Compliance statement
    • Comprehensive Compliance Plan
    • Warning for Shareholders
    • Subscribe for Updates
    • Offering Documents
  • Contact
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • Site map
Acacia Pharma Group Plc
  • Products
    • Overview
    • Therapeutic Areas
    • Marketed Products
    • APD403
  • Partnering
  • Media
    • Press Releases
    • Events
  • Investors
    • Overview
    • Regulatory Announcements
    • Shareholding Structure
    • Share Information
    • Share Price and Charts
    • Financial Reports and Presentations
    • Shareholder Meetings
    • Financial Calendar
    • Analysts
    • Corporate Governance
    • California Compliance statement
    • Comprehensive Compliance Plan
    • Warning for Shareholders
    • Subscribe for Updates
    • Offering Documents
  • Contact

Transforming medicine

Advancing care

Home > Investors > Shareholder Meetings

Investors > Shareholder Meetings

Recommended Acquisition by Eagle – Scheme Document

Recommended Acquisition by Eagle – Proxy Forms

Recommended Acquisition by Eagle – Virtual Meeting Guide, and

Recommended Acquisition by Eagle – S.311A Statement

Annual General Meeting 2021 Results

Notice of 2021 AGM

2021 AGM Form of Proxy

Annual General Meeting 2020 Results

Notice of 2020 AGM

2020 AGM Form of Proxy

Annual General Meeting 2019 Results and Statement

Notice of 2019 AGM

2019 AGM Form of Proxy

Proposed Authorities to Allot Shares and Disapply Pre-emption Rights and Notice of General Meeting on 25 September 2018

Form of Proxy

Investors

  • Overview
  • Regulatory Announcements
  • Shareholding Structure
  • Share Information
  • Share Price and Charts
  • Financial Reports and Presentations
  • Shareholder Meetings
  • Financial Calendar
  • Analysts
  • Corporate Governance
  • California Compliance Statement
  • Warning for Shareholders
  • Subscribe for Updates
  • Offering Documents
Acacia Pharma Group Plc
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • Site map

© 2023 Acacia Pharma Group Plc

(Registered in England and Wales No: 09759376)
Registered office address: The Officers’ Mess, Royston Road, Duxford, Cambridge CB22 4QH, UK

Acacia Pharma Limited (Registered in England and Wales No: 05934843) and Acacia Pharma Inc (Incorporated under the laws of Delaware, No: 5799660) are members of the Acacia Pharma Group

Website by Instinctif Partners

By continuing to use acaciapharma.com you will be agreeing to the website Terms & Conditions, the Privacy Policy, and the use of Cookies.

By continuing to use acaciapharma.com you will be agreeing to the website Terms & Conditions, the Privacy Policy, and the use of Cookies.